Shopping Cart
- Remove All
- Your shopping cart is currently empty
EIDD-2749 (4'-FlU), a ribonucleoside analog, is an orally available RdRp inhibitor with spectroscopic antiviral activity that interrupts the replication of respiratory syncytial virus and SARS-CoV-2.EIDD-2749 attenuates lethal infections of pandemic human and highly pathogenic avian influenza viruses.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $98 | In Stock | |
10 mg | $180 | In Stock | |
25 mg | $392 | In Stock | |
50 mg | $748 | In Stock |
Description | EIDD-2749 (4'-FlU), a ribonucleoside analog, is an orally available RdRp inhibitor with spectroscopic antiviral activity that interrupts the replication of respiratory syncytial virus and SARS-CoV-2.EIDD-2749 attenuates lethal infections of pandemic human and highly pathogenic avian influenza viruses. |
In vitro | EIDD-2749 (20 uM) is effective in synthesizing metabolism in HAE cells and is effective on human airway epithelial organoids[1]. |
In vivo | In Balb/cJ mice (RSV infection model), EIDD-2749 (0.2, 1, 5 mg/kg; oral administration; once daily for 4 days) resulted in a statistically significant reduction in lung virus load[1]. |
Alias | 4'-Fluorouridine, 4'-FlU |
Molecular Weight | 262.19 |
Formula | C9H11FN2O6 |
Cas No. | 1613589-24-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 15 mg/mL (57.21 mM), Sonication is recommended. H2O: 50 mg/mL (190.70 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
DMSO/H2O
H2O
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.